Antibiotic Therapy in the Treatment of COVID-19 Pneumonia: Who and When?

Tat Ming Ng Sean Wei Xiang OngAudrey Y X LooSock Hoon TanHui Lin Tay Min Yi YapDavid C LyeTau Hong LeeBarnaby E Young

Published in: Antibiotics (Basel, Switzerland) (2022)

Empiric antibiotic use in those presenting with COVID-19 pneumonia did not prevent deterioration or mortality. More studies are needed to evaluate strategies to diagnose bacterial co-infections in these patients.

Keyphrases

coronavirus disease
sars cov
end stage renal disease
newly diagnosed
ejection fraction
prognostic factors
peritoneal dialysis
stem cells
cardiovascular disease
respiratory syndrome coronavirus
coronary artery disease
patient reported outcomes
case report
replacement therapy